News
- Author:
- Michele G. Sullivan
Publish date: April 8, 2019
Colchicine was linked to lower levels of inflammatory markers and improved fasting insulin levels and glucose effectiveness.
News
- Author:
- Michele G. Sullivan
Publish date: April 7, 2019
WASHINGTON – About half of those who took 8 mg of CPT-543, a chemically altered form of ruxolitinib, twice a day for 24 weeks, regrew hair –by at l...
News
- Author:
- Michele G. Sullivan
Publish date: April 5, 2019
A large prescription database review found no significantly increased risks of COPD exacerbation, pneumonia, flu, or bronchitis.
News
- Author:
- Michele G. Sullivan
Publish date: April 2, 2019
Results from IDEAS, a prospective imaging study, refined Alzheimer’s disease diagnoses in both amyloid-positive and amyloid-negative cases. Now it ...
News
- Author:
- Michele G. Sullivan
Publish date: March 26, 2019
Two experts drew on both personal experience and extant literature in the debate “Steroids for Pneumonia and Sepsis ... Do You Believe?”
News
- Author:
- Michele G. Sullivan
Publish date: March 26, 2019
When fire is eating entire neighborhoods, or a hurricane is smashing towns like toys, the hospitalist will i...
News
- Author:
- Michele G. Sullivan
Publish date: March 9, 2019
It’s not the Holy Grail of a simple Alzheimer’s blood test for the clinic. But it could be a big benefit in the r...
News
- Author:
- Michele G. Sullivan
Publish date: March 8, 2019
WASHINGTON – PRN1008 blocks BTK receptors on B cells, thus forestalling the B-cell mediated inflammatory cascade.
Opinion
- Author:
- Michele G. Sullivan
Publish date: March 6, 2019
“Initially, not every psychiatrist will be able to offer esketamine ... and that’s probably okay.”
News
- Author:
- Michele G. Sullivan
Publish date: March 5, 2019
Under the FDA-required REMS, prescribers must complete specific training; the drug must be adminstered in office to allow for patient monitoring.
News
- Author:
- Michele G. Sullivan
Publish date: March 3, 2019
WASHINGTON – The human monoclonal antibody is the first to target interleukin-1 alpha in the disorder.
News
- Author:
- Michele G. Sullivan
Publish date: March 3, 2019
WASHINGTON – With some caution, it’s possible to continue agents for psoriasis, atopic dermatitis, and pemphigus.
News
- Author:
- Michele G. Sullivan
Publish date: March 2, 2019
LAS VEGAS – Compared with an office visit, the phone text system virtually eliminated the difference between the number of nonblack and black women...
News
- Author:
- Michele G. Sullivan
Publish date: February 26, 2019
The Oncologic Drugs Advisory Committee expressed concern about the high rate of serious adverse events with the drug being developed to treat multi...
News
- Author:
- Michele G. Sullivan
Publish date: February 21, 2019
Only two – titanium dioxide and zinc oxide – are generally recognized as safe and effective and not misbranded, officials said.
